Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

HT Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$63M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon

Areas of investment

  • Biotechnology
  • Life Science
  • Pharmaceutical
  • Health Care
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of HT Capital:
Typical Co-investors
HT Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after HT Capital:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Healsun Biopharm

Biopharma
Biotechnology
Health Care
Information Technology
Pharmaceutical
$38M19 Aug 2022 Hangzhou, Zhejiang, China

Alebund Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$54M13 Sep 2021 Shanghai, China

RecBio

Health Care
Life Science
$231M11 Nov 2020 Taizhou, Jiangsu, China

Zhinengguo

30 Dec 2015 -

Qukaidan

$30M04 Nov 2015 -

Qukaidan

$25M17 Dec 2014 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent HT Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 63M
Peak activity year 2015
Lead investments 0
Follow on index 0.17
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Healsun Biopharm

Biopharma
Biotechnology
Health Care
Information Technology
Pharmaceutical
$38M19 Aug 2022 Hangzhou, Zhejiang, China

Alebund Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$54M13 Sep 2021 Shanghai, China

RecBio

Health Care
Life Science
$231M11 Nov 2020 Taizhou, Jiangsu, China

Zhinengguo

30 Dec 2015 -

Qukaidan

$30M04 Nov 2015 -

Qukaidan

$25M17 Dec 2014 -
Crunchbase icon

Content report

The following text will be sent to our editors: